BEAUTY FARM MEDICAL AND HEALTH INDUSTRY INC.

Balance Sheet Beauty Farm Medical and Health Industry Inc.

Stocks

2373

KYG0929L1041

Personal Services

Market Closed - Hong Kong S.E. Other stock markets 01:39:02 15/06/2026 pm IST			5-day change	1st Jan Change
17.96 ^HKD	+1.99%		+6.27%	-33.97%

28/03	Beauty Farm Medical and Health Industry Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
27/03	Beauty Farm Medical's Profit, Revenue Rise in 2025	MT

7a878324ac.iaiUjEomUtjOH6HdKvZlEvOktXxEc-SqotwdkjdGYCg.yP2kyztUYomJV9DsZLkSJMr3gEQdJLz56u9_400wGV_H-dXtJW0dh61rzg

Published financial data: BEAUTY FARM MEDICAL AND HEALTH INDUSTRY INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	178.07Cr	163.54Cr	214.51Cr	257.22Cr	300.05Cr
Total Revenues	178.07Cr	163.54Cr	214.51Cr	257.22Cr	300.05Cr
Cost of Goods Sold, Total	95Cr	92Cr	116.8Cr	138.22Cr	152.87Cr
Gross Profit	83Cr	72Cr	98Cr	119Cr	147.19Cr
Selling General & Admin Expenses, Total	57Cr	58Cr	70Cr	85Cr	99Cr
Provision for Bad Debts	13.06L	2L	-54T	39.06L	10.42L
R&D Expenses	1.8Cr	3.12Cr	3.41Cr	3.6Cr	4.19Cr
Other Operating Expenses	-1.5Cr	-2.44Cr	-2.24Cr	-90.34L	-1.45Cr
Other Operating Expenses, Total	58Cr	58Cr	71Cr	88Cr	102.01Cr
Operating Income	26Cr	14Cr	27Cr	31Cr	45Cr
Interest Expense, Total	-2.42Cr	-2.47Cr	-2.48Cr	-2.76Cr	-3.22Cr
Interest And Investment Income	12.83L	30.94L	2.18Cr	2.36Cr	2.27Cr
Net Interest Expenses	-2.29Cr	-2.16Cr	-29.74L	-39.41L	-94.5L
Income (Loss) On Equity Invest.	-	-	-51T	-	-
Currency Exchange Gains (Loss)	-2L	40.3L	3L	-25.51L	5L
Other Non Operating Income (Expenses)	-	-	-8L	9L	-17.67L
EBT, Excl. Unusual Items	23Cr	12Cr	27Cr	30Cr	44Cr
Gain (Loss) On Sale Of Investments	2.34Cr	2.07Cr	2.38Cr	2.09Cr	1.75Cr
Gain (Loss) On Sale Of Assets	-26.4L	-9L	-10.08L	-70.76L	-1.4Cr
Other Unusual Items	-	-72.79L	-	4L	55.2L
EBT, Incl. Unusual Items	26Cr	13Cr	29Cr	32Cr	45Cr
Income Tax Expense	4.68Cr	1.99Cr	5.81Cr	6.54Cr	11Cr
Earnings From Continuing Operations	21Cr	11Cr	23Cr	25Cr	34Cr
Net Income to Company	21Cr	11Cr	23Cr	25Cr	34Cr
Minority Interest	-1.49Cr	-74.23L	-1.45Cr	-2.4Cr	-2.27Cr
Net Income - (IS)	19Cr	10Cr	22Cr	23Cr	32Cr
Net Income to Common Incl Extra Items	19Cr	10Cr	22Cr	23Cr	32Cr
Net Income to Common Excl. Extra Items	19Cr	10Cr	22Cr	23Cr	32Cr
Per Share Items
Net EPS - Basic	0.97	0.52	0.94	0.99	1.38
Basic EPS - Continuing Operations	0.97	0.52	0.94	0.99	1.38
Basic Weighted Average Shares Outstanding	20Cr	20Cr	23Cr	23Cr	23Cr
Net EPS - Diluted	0.97	0.52	0.94	0.99	1.37
Diluted EPS - Continuing Operations	0.97	0.52	0.94	0.99	1.37
Diluted Weighted Average Shares Outstanding	20Cr	20Cr	23Cr	23Cr	23Cr
Normalized Basic EPS	0.66	0.33	0.66	0.72	1.1
Normalized Diluted EPS	0.66	0.33	0.66	0.72	1.09
Dividend Per Share	-	0.34	0.43	0.48	0.63
Payout Ratio	41.95	198.1	40.34	49.24	38.5
Supplemental Items
EBITDA	36Cr	24Cr	39Cr	45Cr	60Cr
EBITA	27Cr	15Cr	28Cr	33Cr	47Cr
EBIT	26Cr	14Cr	27Cr	31Cr	45Cr
EBITDAR	37Cr	25Cr	40Cr	48Cr	62Cr
Effective Tax Rate - (Ratio)	18.33	15.28	20.17	20.58	24.39
Current Domestic Taxes	4.49Cr	2.94Cr	4.13Cr	3.46Cr	7.55Cr
Total Current Taxes	4.49Cr	2.94Cr	4.13Cr	3.46Cr	7.55Cr
Deferred Domestic Taxes	-	-92.47L	1.54Cr	2.92Cr	3.1Cr
Total Deferred Taxes	34.61L	-92.47L	1.54Cr	2.92Cr	3.1Cr
Normalized Net Income	13Cr	6.63Cr	15Cr	17Cr	25Cr
Interest on Long-Term Debt	2.42Cr	2.47Cr	2.48Cr	2.45Cr	2.49Cr
Supplemental Operating Expense Items
Marketing Expenses	3.34Cr	3.65Cr	4.41Cr	5.11Cr	6.33Cr
Selling and Marketing Expenses	30Cr	29Cr	38Cr	46Cr	51Cr
General and Administrative Expenses	27Cr	29Cr	32Cr	39Cr	48Cr
Research And Development Expense From Footnotes	1.8Cr	3.12Cr	3.41Cr	3.6Cr	4.19Cr
Net Rental Expense, Total	98.97L	1.05Cr	1.66Cr	2.93Cr	2.14Cr
Imputed Operating Lease Interest Expense	37.19L	39.78L	60.38L	99.85L	54.4L
Imputed Operating Lease Depreciation	61.78L	64.94L	1.05Cr	1.93Cr	1.6Cr
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-4L	1.68Cr
Stock-Based Comp., Other (Total)	62.9L	1.42Cr	1.09Cr	-	-
Total Stock-Based Compensation	62.9L	1.42Cr	1.09Cr	-4L	1.68Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	16Cr	16Cr	22Cr	46Cr	110.99Cr
Short Term Investments	-	12Cr	38Cr	46Cr	52Cr
Trading Asset Securities, Total	93Cr	63Cr	96Cr	91Cr	91Cr
Total Cash And Short Term Investments	108.36Cr	91Cr	157.42Cr	183.08Cr	254.19Cr
Accounts Receivable, Total	4.22Cr	5.76Cr	6.54Cr	5.69Cr	7.4Cr
Other Receivables	53.47L	1.43Cr	2.59Cr	1.79Cr	1.12Cr
Notes Receivable	-	-	-	-	-
Total Receivables	4.75Cr	7.19Cr	9.13Cr	7.48Cr	8.52Cr
Inventory	13Cr	19Cr	23Cr	21Cr	16Cr
Restricted Cash	1.03Cr	1.03Cr	1.05Cr	2.84Cr	2.9Cr
Other Current Assets, Total	3.43Cr	6.98Cr	2.86Cr	4.48Cr	4.62Cr
Total Current Assets	130.95Cr	124.78Cr	193.59Cr	218.6Cr	285.79Cr
Gross Property Plant And Equipment	159.96Cr	174.78Cr	189.88Cr	209.26Cr	206.52Cr
Accumulated Depreciation	-81Cr	-89Cr	-94Cr	-112.84Cr	-119.4Cr
Net Property Plant And Equipment	79Cr	86Cr	95Cr	96Cr	87Cr
Long-term Investments	74T	47T	3L	75.91L	5.8Cr
Goodwill	19Cr	20Cr	22Cr	65Cr	71Cr
Other Intangibles, Total	9.03Cr	8.33Cr	8Cr	35Cr	34Cr
Deferred Tax Assets Long-Term	3.5Cr	4.42Cr	4.21Cr	4.17Cr	2.27Cr
Other Long-Term Assets, Total	6.24Cr	6.39Cr	7.19Cr	7.29Cr	19Cr
Total Assets	247.73Cr	249.54Cr	330.2Cr	427.65Cr	504.62Cr
Liabilities
Accounts Payable, Total	1.54Cr	78.57L	2.14Cr	2.99Cr	3.64Cr
Accrued Expenses, Total	22Cr	20Cr	24Cr	30Cr	34Cr
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	1.98Cr	8.95Cr
Current Portion of Leases	16Cr	15Cr	17Cr	22Cr	21Cr
Current Income Taxes Payable	3.19Cr	3.4Cr	4.85Cr	4.23Cr	7.64Cr
Unearned Revenue Current, Total	134.77Cr	140.81Cr	149.25Cr	197.92Cr	209.43Cr
Other Current Liabilities	7.84Cr	11Cr	8.07Cr	15Cr	6.69Cr
Total Current Liabilities	185.38Cr	190.91Cr	205.2Cr	273.89Cr	290.95Cr
Long-Term Debt	-	-	-	13Cr	64Cr
Long-Term Leases	35Cr	37Cr	39Cr	36Cr	35Cr
Deferred Tax Liability Non Current	87.44L	86.47L	2.2Cr	7.2Cr	7.44Cr
Total Liabilities	221.48Cr	229.23Cr	246.78Cr	330.12Cr	397.93Cr
Common Stock, Total	-	7T	8T	8T	8T
Additional Paid In Capital	-	8.44Cr	47Cr	36Cr	25Cr
Retained Earnings	19Cr	10Cr	32Cr	55Cr	86Cr
Treasury Stock	-	-	-68.16L	-	-2.49Cr
Comprehensive Income and Other	6.54Cr	20.98L	2.3Cr	3.84Cr	-6.5Cr
Total Common Equity	26Cr	19Cr	80Cr	94Cr	102.2Cr
Minority Interest	51.73L	1.44Cr	3.23Cr	3.06Cr	4.49Cr
Total Equity	26Cr	20Cr	83Cr	98Cr	106.69Cr
Total Liabilities And Equity	247.73Cr	249.54Cr	330.2Cr	427.65Cr	504.62Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	20Cr	24Cr	24Cr	24Cr	23Cr
ECS Total Common Shares Outstanding	20Cr	10Cr	24Cr	24Cr	23Cr
Book Value / Share	1.29	1.83	3.4	4.01	4.35
Tangible Book Value	-2.72Cr	-9.08Cr	50Cr	-5.94Cr	-2.68Cr
Tangible Book Value Per Share	-0.14	-0.88	2.14	-0.25	-0.11
Total Debt	52Cr	53Cr	56Cr	73Cr	129.44Cr
Net Debt	-57Cr	-39Cr	-101.11Cr	-110.02Cr	-124.75Cr
Debt Equivalent Oper. Leases	7.92Cr	8.38Cr	13Cr	23Cr	17Cr
Minority Interest, Total (Incl. Fin. Div)	51.73L	1.44Cr	3.23Cr	3.06Cr	4.49Cr
Equity Method Investments, Total	-	-	2L	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Finished Goods, Total	10Cr	15Cr	20Cr	16Cr	11Cr
Land - (BS)	7.8Cr	7.45Cr	7.8Cr	7.8Cr	7.8Cr
Buildings, Total	4.08Cr	4.08Cr	4.08Cr	4.08Cr	4.08Cr
Machinery, Total	21Cr	24Cr	31Cr	36Cr	35Cr
Full Time Employees	-	3.71T	3.94T	5.61T	5.34T
Accumulated Allowance for Doubtful Accounts (Supple)	24.93L	24.68L	24.14L	63.2L	73.62L

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	19Cr	10Cr	22Cr	23Cr	32Cr
Depreciation & Amortization - CF	26Cr	28Cr	31Cr	36Cr	38Cr
Amortization of Goodwill and Intangible Assets - (CF)	97.59L	1.32Cr	1.27Cr	2.13Cr	2.31Cr
Depreciation & Amortization, Total	27Cr	29Cr	33Cr	38Cr	40Cr
Amortization of Deferred Charges, Total - (CF)	22.99L	34.29L	40.18L	53.4L	63.43L
(Gain) Loss From Sale Of Asset	26.4L	9L	10.08L	70.76L	1.4Cr
(Gain) Loss on Sale of Investments - (CF)	-2.34Cr	-2.07Cr	-2.38Cr	-2.07Cr	-1.75Cr
Asset Writedown & Restructuring Costs	34T	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	51T	-	-
Stock-Based Compensation (CF)	62.9L	1.42Cr	1.09Cr	-4L	1.68Cr
Provision and Write-off of Bad Debts	13.06L	2L	-54T	39.06L	10.42L
Other Operating Activities, Total	4.06Cr	3.36Cr	5.52Cr	5.34Cr	7.89Cr
Change In Accounts Receivable	-93.16L	-3.53Cr	-2.47Cr	6.28Cr	2.27Cr
Change In Inventories	-3.17Cr	-4.64Cr	-4.79Cr	5.63Cr	5.22Cr
Change In Accounts Payable	5.92Cr	-2.63Cr	4.58Cr	-97.41L	4.82Cr
Change in Unearned Revenues	17Cr	6.15Cr	6.19Cr	5.08Cr	6.11Cr
Change in Other Net Operating Assets	-1.03Cr	-30T	-2L	-1.8Cr	-5L
Cash from Operations	67Cr	38Cr	63Cr	80Cr	100Cr
Capital Expenditure	-13Cr	-14Cr	-16Cr	-11Cr	-6.71Cr
Sale of Property, Plant, and Equipment	-	2L	6L	26.93L	34T
Cash Acquisitions	-1.13Cr	-42.02L	-74.96L	-25Cr	-25Cr
Divestitures	36.63L	-21.25L	-	80T	10L
Investment in Marketable and Equity Securities, Total	-24Cr	20Cr	-55Cr	-41.34L	-9.95Cr
Other Investing Activities, Total	-	-	60.62L	2Cr	1.89Cr
Cash from Investing	-39Cr	5.36Cr	-71Cr	-34Cr	-40Cr
Long-Term Debt Issued, Total	-	-	-	16Cr	61Cr
Total Debt Issued	-	-	-	16Cr	61Cr
Long-Term Debt Repaid, Total	-18Cr	-23Cr	-23Cr	-27Cr	-30Cr
Total Debt Repaid	-18Cr	-23Cr	-23Cr	-27Cr	-30Cr
Issuance of Common Stock	1.83Cr	39.76L	51Cr	-	-
Repurchase of Common Stock	-	-	-	-	-2.49Cr
Common Dividends Paid	-8.12Cr	-20Cr	-8.7Cr	-11Cr	-12Cr
Common & Preferred Stock Dividends Paid	-8.12Cr	-20Cr	-8.7Cr	-11Cr	-12Cr
Other Financing Activities, Total	-2.44Cr	-11.03L	-5.37Cr	50.59L	-11Cr
Cash from Financing	-27Cr	-43Cr	13Cr	-22Cr	5.18Cr
Foreign Exchange Rate Adjustments	2L	40.3L	1.21Cr	-5L	-7L
Net Change in Cash	1.37Cr	68.36L	6.02Cr	23Cr	65Cr
Supplemental Items
Cash Interest Paid	17T	-	-	28.81L	71.23L
Cash Income Tax Paid (Refund)	4.59Cr	2.71Cr	2.82Cr	4.25Cr	5.76Cr
Levered Free Cash Flow	50Cr	20Cr	44Cr	106.66Cr	77Cr
Unlevered Free Cash Flow	52Cr	21Cr	45Cr	108.38Cr	79Cr
Change In Net Working Capital	-21Cr	4.37Cr	-10Cr	-62Cr	-15Cr
Net Debt Issued / Repaid	-18Cr	-23Cr	-23Cr	-12Cr	31Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.03	3.41	5.8	5.1	6.06
Return on Total Capital	22.44	11.25	15.82	12.46	13.88
Return On Equity %	103.33	47.47	44.37	27.91	33.32
Return on Common Equity	97.17	46.23	43.54	26.16	32.29
Margin Analysis
Gross Profit Margin %	46.82	43.89	45.55	46.26	49.05
SG&A Margin	32.12	35.18	32.47	33.04	33.05
EBITDA Margin %	20.01	14.79	18.01	17.51	20.11
EBITA Margin %	15.01	9.1	13.13	12.85	15.83
EBIT Margin %	14.46	8.29	12.54	12.02	15.06
Income From Continuing Operations Margin %	11.7	6.76	10.73	9.82	11.34
Net Income Margin %	10.86	6.3	10.05	8.88	10.58
Net Avail. For Common Margin %	10.86	6.3	10.05	8.88	10.58
Normalized Net Income Margin	7.39	4.05	7.06	6.44	8.43
Levered Free Cash Flow Margin	28.25	12	20.32	41.47	25.58
Unlevered Free Cash Flow Margin	29.1	12.94	21.05	42.13	26.25
Asset Turnover
Asset Turnover	0.78	0.66	0.74	0.68	0.64
Fixed Assets Turnover	2.3	1.99	2.36	2.68	3.27
Receivables Turnover (Average Receivables)	45.16	32.78	34.86	42.07	45.86
Inventory Turnover (Average Inventory)	8.3	5.75	5.61	6.3	8.43
Short Term Liquidity
Current Ratio	0.71	0.65	0.94	0.8	0.98
Quick Ratio	0.61	0.51	0.81	0.7	0.9
Operating Cash Flow to Current Liabilities	0.36	0.2	0.3	0.29	0.34
Days Sales Outstanding (Average Receivables)	8.08	11.13	10.47	8.7	7.96
Days Outstanding Inventory (Average Inventory)	43.97	63.44	65.1	58.06	43.31
Average Days Payable Outstanding	6.15	4.39	4.4	6.91	8.19
Cash Conversion Cycle (Average Days)	45.9	70.19	71.17	59.85	43.08
Long Term Solvency
Total Debt/Equity	196.34	258.73	67.5	74.91	121.32
Total Debt / Total Capital	66.25	72.12	40.3	42.83	54.82
LT Debt/Equity	134.18	184.4	47.2	50.29	93.29
Long-Term Debt / Total Capital	45.28	51.4	28.18	28.75	42.15
Total Liabilities / Total Assets	89.4	91.86	74.74	77.2	78.86
EBIT / Interest Expense	10.63	5.49	10.84	11.22	14.05
EBITDA / Interest Expense	21.9	17.37	24.05	24.91	26.43
(EBITDA - Capex) / Interest Expense	16.4	11.68	17.63	20.77	24.35
Total Debt / EBITDA	0.97	1.22	0.94	1.06	1.52
Net Debt / EBITDA	-1.07	-0.9	-1.69	-1.6	-1.47
Total Debt / (EBITDA - Capex)	1.3	1.82	1.29	1.28	1.65
Net Debt / (EBITDA - Capex)	-1.43	-1.33	-2.31	-1.92	-1.59
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.46	-8.16	31.16	19.91	16.65
Gross Profit, 1 Yr. Growth %	19.11	-13.91	36.12	21.79	23.69
EBITDA, 1 Yr. Growth %	17.8	-32.12	59.63	16.57	34
EBITA, 1 Yr. Growth %	25.92	-44.32	89.1	17.35	43.64
EBIT, 1 Yr. Growth %	26.26	-47.36	98.17	14.97	46.09
Earnings From Cont. Operations, 1 Yr. Growth %	36.9	-46.95	108.21	9.71	34.77
Net Income, 1 Yr. Growth %	28.16	-46.71	109.15	5.94	39
Normalized Net Income, 1 Yr. Growth %	19.15	-49.61	128.36	9.48	52.59
Diluted EPS Before Extra, 1 Yr. Growth %	28.16	-46.79	82.26	5.32	38.38
Accounts Receivable, 1 Yr. Growth %	14.89	36.62	13.61	-13.13	30.16
Inventory, 1 Yr. Growth %	41.63	38.49	24.92	-10.46	-24.89
Net Property, Plant and Equip., 1 Yr. Growth %	3.12	9.42	10.98	1.04	-9.65
Total Assets, 1 Yr. Growth %	17.79	0.73	32.32	29.51	18
Tangible Book Value, 1 Yr. Growth %	-78.36	234.42	-655.29	-111.78	-54.93
Common Equity, 1 Yr. Growth %	82.69	-26.66	324.85	17.8	8.19
Cash From Operations, 1 Yr. Growth %	-1.56	-42.98	63.75	27.36	25.42
Capital Expenditures, 1 Yr. Growth %	97.27	5.72	13.1	-28.29	-41.25
Levered Free Cash Flow, 1 Yr. Growth %	-10.8	-61	122.12	144.64	-28.03
Unlevered Free Cash Flow, 1 Yr. Growth %	-10.68	-59.16	113.24	140.05	-27.31
Dividend Per Share, 1 Yr. Growth %	-	-	24.65	12.51	28.93
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	12.59	4.3	9.75	25.41	18.27
Gross Profit, 2 Yr. CAGR %	8.49	1.26	8.25	28.75	22.73
EBITDA, 2 Yr. CAGR %	12.87	-10.58	4.13	36.42	24.98
EBITA, 2 Yr. CAGR %	13.14	-16.27	2.67	48.97	29.83
EBIT, 2 Yr. CAGR %	13.18	-18.47	2.21	50.94	29.6
Earnings From Cont. Operations, 2 Yr. CAGR %	18.88	-14.78	5.1	51.14	21.6
Net Income, 2 Yr. CAGR %	17.42	-17.35	5.58	48.85	21.35
Normalized Net Income, 2 Yr. CAGR %	13.46	-22.52	7.27	58.11	29.25
Diluted EPS Before Extra, 2 Yr. CAGR %	17.42	-17.42	-1.52	38.55	20.72
Accounts Receivable, 2 Yr. CAGR %	17.93	25.29	24.58	-0.66	6.34
Inventory, 2 Yr. CAGR %	4.93	40.06	31.53	5.76	-17.99
Net Property, Plant and Equip., 2 Yr. CAGR %	-4.38	6.23	10.2	5.89	-4.45
Total Assets, 2 Yr. CAGR %	16.71	8.93	15.45	30.91	23.62
Tangible Book Value, 2 Yr. CAGR %	-61.5	-14.93	330.93	-19.11	-76.96
Common Equity, 2 Yr. CAGR %	133.17	15.75	76.52	123.71	12.89
Cash From Operations, 2 Yr. CAGR %	20.25	-25.08	-3.37	44.41	26.38
Capital Expenditures, 2 Yr. CAGR %	11.13	44.42	9.35	-9.94	-35.1
Levered Free Cash Flow, 2 Yr. CAGR %	-	-41.02	-6.91	133.11	32.69
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-39.61	-6.66	126.25	32.09
Dividend Per Share, 2 Yr. CAGR %	-	-	-	17.96	21.52
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	5.2	12.58	13.04	22.42
Gross Profit, 3 Yr. CAGR %	-	0.45	11.76	12.59	27.04
EBITDA, 3 Yr. CAGR %	-	-4.73	8.5	8.13	35.61
EBITA, 3 Yr. CAGR %	-	-10.68	9.9	7.35	47.17
EBIT, 3 Yr. CAGR %	-	-12.31	9.67	6.3	49.31
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-9.15	14.78	6.61	45.47
Net Income, 3 Yr. CAGR %	-	-9.76	12.62	5.7	45.49
Normalized Net Income, 3 Yr. CAGR %	-	-13.44	11.09	8	56.25
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-9.81	7.52	0.71	38.49
Accounts Receivable, 3 Yr. CAGR %	-	23.86	21.27	10.47	8.71
Inventory, 3 Yr. CAGR %	-	15.1	34.82	15.71	-5.64
Net Property, Plant and Equip., 3 Yr. CAGR %	-	0.02	7.79	7.06	0.44
Total Assets, 3 Yr. CAGR %	-	11.12	16.23	19.96	26.46
Tangible Book Value, 3 Yr. CAGR %	-	-20.86	58.98	29.83	-33.44
Common Equity, 3 Yr. CAGR %	-	58.57	78.55	54.26	75.6
Cash From Operations, 3 Yr. CAGR %	-	-6.23	-2.77	5.94	37.78
Capital Expenditures, 3 Yr. CAGR %	-	9.3	33.12	-5	-21.9
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-8.22	28.47	57.55
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-8.02	27.88	54.95
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	22.23
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	12.86	14.82
Gross Profit, 5 Yr. CAGR %	-	-	-	10.93	16.03
EBITDA, 5 Yr. CAGR %	-	-	-	10	14.82
EBITA, 5 Yr. CAGR %	-	-	-	9.63	17.48
EBIT, 5 Yr. CAGR %	-	-	-	9	17.24
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	11.36	17.46
Net Income, 5 Yr. CAGR %	-	-	-	10.24	16.04
Normalized Net Income, 5 Yr. CAGR %	-	-	-	10.15	18.02
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	7.09	12.62
Accounts Receivable, 5 Yr. CAGR %	-	-	-	13.4	15.06
Inventory, 5 Yr. CAGR %	-	-	-	11.27	10.51
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	2.33	2.71
Total Assets, 5 Yr. CAGR %	-	-	-	18.65	19.13
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-20.17	-26.58
Common Equity, 5 Yr. CAGR %	-	-	-	81.97	48.64
Cash From Operations, 5 Yr. CAGR %	-	-	-	11.45	7.98
Capital Expenditures, 5 Yr. CAGR %	-	-	-	1.15	-0.13
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	6.36
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	6.31